Capricor Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
15.00
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
1
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.29
|
-0.26
|
0.03
|
10.34%
|
|
2022-06-30
|
-0.25
|
-0.29
|
-0.04
|
-16.00%
|
|
2022-03-31
|
0.00
|
-0.32
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.19
|
-0.26
|
-0.07
|
-36.84%
|
|
2021-09-30
|
-0.22
|
-0.17
|
0.05
|
22.73%
|
|
2021-06-30
|
-0.23
|
-0.21
|
0.02
|
8.70%
|
|
2021-03-31
|
0.00
|
-0.23
|
0.00
|
0.00%
|
|
2020-12-31
|
-0.20
|
-0.21
|
-0.01
|
-5.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.87
|
|
2021-12-31
|
-0.87
|
|
2020-12-31
|
-0.94
|
|
2019-12-31
|
-2.16
|
|
2018-12-31
|
-5.30
|
|
2017-12-31
|
-4.07
|
|
2016-12-31
|
-1.02
|
|
2015-12-31
|
-0.81
|
|
2014-12-31
|
-2.64
|
|
2013-12-31
|
-22.95
|
|
2012-12-31
|
-33.08
|
|
2011-12-31
|
-67.29
|
|
2010-12-31
|
-95.00
|
|
2009-12-31
|
-155.00
|
|
2008-12-31
|
-275.00
|
|
2007-12-31
|
-223.63
|
|
2006-12-31
|
-48.43
|
|
2004-12-31
|
-12.02
|
|
2003-12-31
|
-10.70
|
|
2002-12-31
|
-14.42
|